Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Unlabelled: Among the idiopathic interstitial pneumonias (IIP), the two entities IPF and NSIP seem to be clinically related, but NSIP has a better outcome. The proteomic signatures which distinguish NSIP from IPF remain still elusive. We therefore performed comparative proteomic analysis of peripheral lung tissue from patients with sporadic IPF (n=14) and fibrotic NSIP (fNSIP, n=8) and organ donors (Controls, n=10), by using the 2-dimensional DIGE technique and MALDI-TOF-MS. The study revealed that the proteomic profiles of IPF and fNSIP were quite similar. Among the upregulated proteins in IPF and fNSIP were stress-induced genes involved in the ER stress-pathway, whereas downregulated proteins in IPF and fNSIP included antiapoptotic factors and antifibrotic molecules. The comparison fNSIP versus IPF indicated upregulation of subunits of the proteasome activator complex and antioxidant enzymes of the peroxiredoxin family. We conclude, that only few protein expression changes exist between IPF and fNSIP, and that epithelial ER- and oxidative stress play a major role in the pathogenesis of both diseases. In contrast to IPF, intracellular clearance of ROS and misfolded protein carbonyls seem to be enhanced in fNSIP due to enhanced expression of antioxidant acting proteins, and may explain the better outcome and survival in patients with fNSIP.

Biological Significance: IPF and fibrotic NSIP (fNSIP) belong to the idiopathic interstitial pneumonias and are usually fatal, but fNSIP has a better outcome. In order to identify molecular mechanisms and differences between IPF and fNSIP, we herein present results of a comparative proteome analysis of IPF, fNSIP and control lung tissue. Our data including validation experiments suggest that ER stress and a general stress-response as well as the decline of antioxidant capacity in alveolar epithelium is key in the pathogenesis of IPF and fNSIP. In addition, we could observe a signature of an increased alveolar epithelial protection against oxidative and ER-stress in fNSIP as compared to IPF, which could help to explain the better outcome of fNSIP patients.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jprot.2013.04.033DOI Listing

Publication Analysis

Top Keywords

ipf fnsip
28
better outcome
16
ipf
15
fnsip
14
lung tissue
12
comparative proteome
8
proteome analysis
8
tissue patients
8
organ donors
8
idiopathic interstitial
8

Similar Publications

BAL cellularity and lymphocyte immunophenotyping offer insights into lung inflammatory status. Natural killer (NK) cells are efficient effector cells, producing pro-inflammatory cytokines. A better understanding of the biology of NK cells in BAL in the lungs is necessary to improve the pathogenesis of fibrotic ILD and develop prospective targeted treatments.

View Article and Find Full Text PDF
Article Synopsis
  • - The study investigates the use of a computer-aided system to enhance the diagnostic capabilities of general radiologists in identifying usual interstitial pneumonia (UIP) patterns in CT scans of patients with interstitial pulmonary fibrosis (IPF).
  • - Researchers analyzed CT data from 60 scans, comparing the diagnostic accuracy of radiologists both with and without the assistance of the computer system, revealing a significant improvement in accuracy when using the system.
  • - The results indicated that using the computer-aided system not only boosted diagnostic confidence among less experienced radiologists but also correlated with a worse prognosis for patients diagnosed with UIP, suggesting its potential clinical importance.
View Article and Find Full Text PDF

Background: The soluble receptor for advanced glycation end-products (sRAGE) has been suggested that it acts as a decoy for capturing advanced glycation end-products (AGEs) and inhibits the activation of the oxidative stress and apoptotic pathways. Lung AGEs/sRAGE is increased in idiopathic pulmonary fibrosis (IPF). The objective of the study was to evaluate the AGEs and sRAGE levels in serum as a potential biomarker in IPF.

View Article and Find Full Text PDF
Article Synopsis
  • - Pirfenidone is approved in the EU for mild to moderate idiopathic pulmonary fibrosis (IPF) but other progressive fibrotic lung diseases may benefit from antifibrotic therapy, highlighting the need for effective treatments beyond conventional anti-inflammatory options.
  • - The study protocol aims to include patients with various types of progressive fibrotic lung diseases who show disease progression despite current therapies, focusing on specific conditions like CVD-LF, fNSIP, cHP, and ALF.
  • - By targeting patients with significant disease progression, the study addresses a critical need for treatment solutions in interstitial lung disease (ILD), increasing the potential for meaningful evaluation of therapy effectiveness.
View Article and Find Full Text PDF

Purpose: To compare computer-aided diagnostic results with histological findings obtained by surgical biopsy and evaluate whether subpleural lesion volumes can aid identification of idiopathic pulmonary fibrosis (IPF).

Materials And Methods: We retrospectively analyzed computed tomography (CT) images of 79 patients (43 with fibrosing nonspecific interstitial pneumonia (fNSIP) and 36 with IPF) using the Gaussian Histogram Normalized Correlation (GHNC) system. We determined the H-pattern based on honeycomb and/or fibrosis with traction bronchiectasis on CT, and measured the H-pattern volume ratio at the biopsy sites and in the subpleural area.

View Article and Find Full Text PDF